These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 15336473

  • 1. A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults.
    Loebermann M, Kollaritsch H, Ziegler T, Rendi-Wagner P, Chambonneau L, Dumas R, Lafrenz M.
    Clin Ther; 2004 Jul; 26(7):1084-91. PubMed ID: 15336473
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.
    Overbosch D, Peyron F, Picot N, Varichon JP, Dumas R, Chambonneau L, Weber F.
    J Travel Med; 2005 Jul; 12(6):319-26. PubMed ID: 16343383
    [Abstract] [Full Text] [Related]

  • 4. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
    Beran J, Beutels M, Levie K, Van Damme P, Dieussaert I, Gillet M, Van Hoecke C, Tornieporth N.
    J Travel Med; 2000 Jul; 7(5):246-52. PubMed ID: 11231208
    [Abstract] [Full Text] [Related]

  • 5. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study.
    Lau CL, Streeton CL, David MC, Sly PD, Mills DJ.
    J Travel Med; 2016 Feb; 23(2):tav023. PubMed ID: 26883924
    [Abstract] [Full Text] [Related]

  • 6. Concomitant vaccination against hepatitis A and typhoid fever.
    Van Hoecke C, Lebacq E, Beran J, Prymula R, Collard F.
    J Travel Med; 1998 Sep; 5(3):116-20. PubMed ID: 9772328
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
    Jong EC, Kaplan KM, Eves KA, Taddeo CA, Lakkis HD, Kuter BJ.
    J Travel Med; 2002 Sep; 9(2):66-70. PubMed ID: 12044272
    [Abstract] [Full Text] [Related]

  • 10. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R, Forrat R, Lang J, Farinelli T, Loutan L.
    Adv Ther; 1997 Sep; 14(4):160-7. PubMed ID: 10174195
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
    Miyazu M, Kikuchi H, Hamada A, Fukushima S, Ouchi K, Bosch Castells V, Mihara H, Bonnet MC.
    Vaccine; 2015 Nov 27; 33(48):6697-702. PubMed ID: 26518404
    [Abstract] [Full Text] [Related]

  • 14. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
    Ramonet M, da Silveira TR, Lisker-Melman M, Rüttimann R, Pernambuco E, Cervantes Y, Cañero-Velasco MC, Falleiros-Carvalho LE, Azevedo T, Targa-Ferreira C, Clemens SA.
    Arch Med Res; 2002 Nov 27; 33(1):67-73. PubMed ID: 11825634
    [Abstract] [Full Text] [Related]

  • 15. A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.
    Cartee RT, Thanawastien A, Griffin Iv TJ, Mekalanos JJ, Bart S, Killeen KP.
    PLoS Negl Trop Dis; 2020 Jan 27; 14(1):e0007912. PubMed ID: 31905228
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study.
    Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM.
    Clin Infect Dis; 2015 Aug 01; 61(3):393-402. PubMed ID: 25870324
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vaccines for preventing typhoid fever.
    Anwar E, Goldberg E, Fraser A, Acosta CJ, Paul M, Leibovici L.
    Cochrane Database Syst Rev; 2014 Jan 02; (1):CD001261. PubMed ID: 24385413
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.